KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- Evaluating Empagliflozin’s Impact on Cardiovascular Outcomes in Patients with T2D | AHA 2024 November 20, 2024Two posted presented at the American Heart Association’s 2024 Scientific Sessions explored empagliflozin among patients with type 2 diabetes and cardiovascular risk.
- Rochester Pharmacy Access Coalition Uniting to Fill Gaps from Pharmacy Closures November 20, 2024A collection of hospitals in Rochester, New York, have teamed up to create better access to prescription drugs and combat the city’s pharmacy desert issue.
- Real-Time Pharmacist Feedback Improves Heart Failure Medication Management | AHA 2024 November 20, 2024Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.
- Assessing SGLT-2 Inhibitors in Patients with T2D, Cardiovascular Complications | AHA 2024 November 20, 2024Three research posters presented at the American Heart Association’s 2024 Scientific Sessions looked into the use of SGLT-2 inhibitors in patients with type 2 diabetes and cardiovascular complications.
- Finerenone Safety, Efficacy for HFmrEF, HFpEF Evaluated by Sex November 19, 2024Study results are especially important for women, who are more likely to experience heart failure with mildly reduced or preserved ejection fraction.
- Eating Problems, Diabetes Distress Associated with Worse Time-in-Range | AHA 2024 November 19, 2024Patients with type 2 diabetes who had eating problems and higher levels of diabetes distress had worse time-in-range.
- Over Half of US Population Concerned About Prescription Drug Access, Prices November 19, 2024Wolters Kluwer Health conducted a survey of just over 1000 respondents to get US adults’ feelings about notable trends in the pharmacy industry.
- Pain After Traumatic Injury Worse for Younger Adults Than Those 65 and Over November 19, 2024Researchers aimed to determine the frequency of pain assessments and the extent of pain scores by age for patients undergoing traumatic surgery.
- Medication Optimization Needed for Patients with Long COVID November 19, 2024Investigators said there is an imperative to optimize medication utilization and explore the consequences of medication burden on treatment outcomes in patients with long COVID.
- Community Pharmacies Must Diversify Their Revenue Streams to Survive in Today’s Landscape November 19, 2024Drug Topics talked with Kelly Malkamaki, pharmacist, former independent community pharmacy owner, and senior product pharmacy analyst at AssureCare, about how community pharmacies can continue to thrive with decreased medication reimbursement rates.
Pharmacy Times articles
- Increase of Vitamin D Supplements Could Lower Blood Pressure Among Older Individuals With Obesity November 20, 2024Vitamin D and calcium decreased systolic and diastolic blood pressure among older individuals with obesity.
- Investigators Present New Data About HPV Vaccine, Supporting Its Use November 20, 2024Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.
- Nasal Swab Test Can Predict COVID-19 Severity Through Autoantibody Analysis November 20, 2024Severity of a COVID-19 illness could be determined by examining autoantibodies in the nasal cavity, allowing more personalized treatment protocols.
- Study Finds Nearly 75% of Adults 25 and Older Have Overweight or Obesity November 20, 2024If patterns and trends were to continue, the authors predict that nationwide overweight and obesity prevalence in adults will surpass 80% by 2050.
- Early Asthma Onset Associated With Memory and Executive Function Difficulties in Children November 20, 2024Inflammation associated with asthma in children could perturb neurodevelopment.
- Payment Disrupters and Opportunities: Key Trends That Impacted Pharmacy in 2024 November 20, 2024PBM reforms and regulatory changes have reshaped the industry landscape.
- Alzheimer Disease Treatment Can Improve Population Health and Health Equity November 20, 2024Policies that focus on earlier diagnosis, treatment initiation, and expanded access to treatment can further improve treatment and health equity impacts.
- Condition Watch: Respiratory Syncytial Virus November 20, 2024
- Updates in the Treatment of Moderate to Severe Atopic Dermatitis: A Focus on JAK Inhibitors November 20, 2024Treatment often involves a combination of preventive measures, topical therapies, and systemic treatments.
- FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa November 20, 2024Bimekizumab-bkzx is the first and only approved medication that targets both interleukin (IL) 17F and IL-17A.
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com